Mid-afternoon market update: S&P 500 turns negative; Vaccinex (VCNX Stock) shares spike higher
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFERToward the end of trading Friday, the Dow traded up 0.09% to 31,520.48 while the NASDAQ rose 0.02% to 13,868.58. However, the S&P fell 0.18% to 3,906.96.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 27,896,700 cases with around 493,110 deaths. India confirmed a total of at least 10,963,390 confirmed cases and 156,110 deaths, while Brazil reported over 10,030,620 COVID-19 cases with 243,450 deaths. In total, there were at least 110,394,360 cases of COVID-19 worldwide with over 2,443,540 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Industrials shares rose 1.5% on Friday. Meanwhile, top gainers in the sector included Energous Corporation WATT 72.04%, up 68%, and The ExOne Company XONE 15.04%, up 16%.
In trading on Friday, utilities shares fell by 1.3%.
Top Headline
Deere & Company DE 10.82% reported better-than-expected earnings for its fourth quarter.
Deere reported quarterly earnings of $3.87 per share, beating analysts’ estimates of $2.16 per share. The company’s quarterly sales came in at $9.11 billion, versus expectations of $7.21 billion.
Equities Trading UP
Vaccinex, Inc. VCNX 85.71% shares shot up 88% to $5.40 after the company announced the signing of multiproject deals with two prominent pharma companies that Vaccinex did not identify. The collaborations, Vaccinex said, will focus on using ActivMAb, its antibody discovery and novel viral display platform, for antibody discovery against complex antigens such as GPCRs and ion channels.
Shares of Evolus, Inc. EOLS 68.57% got a boost, shooting 70% to $12.17. Evolus, AbbVie, and Medytox announced settlement agreements to fully resolve all outstanding litigation, including the United States International Trade Commission (ITC) case regarding the sale of Jeuveau. It is a prescription medicine injected into muscles and used in adults temporarily to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines).
Casa Systems Inc CASA 36.8% shares were also up, gaining 37% to $11.67 after the company reported better-than-expected Q4 results and issued strong FY21 sales guidance.
Check out these big movers of the day
Equities Trading DOWN
PDF Solutions, Inc. PDFS 14.15% shares tumbled 14% to $18.28 after reporting a loss for the fourth quarter.
Shares of Rackspace Technology, Inc. RXT 16.61% were down 15% to $21.14 after the company issued FY21 earnings guidance below estimates.
Conduent Incorporated CNDT 12.89% was down, falling 14% to $4.99 after the company reported Q4 earnings results.
Commodities
In commodity news, oil traded down 1.6% to $59.53, while gold traded up 0.3% to $1,779.70.
Silver traded up 1% Friday to $27.335 while copper rose 4.2% to $4.0660.
Euro zone
European shares closed higher today. The eurozone’s STOXX 600 rose 0.53%, the Spanish Ibex Index rose 1.16% and the German DAX 30 gained 0.77%. Meanwhile, the French CAC 40 rose 0.79%, London’s FTSE 100 rose 0.1% and Italy’s FTSE MIB rose 0.94%.
The Eurozone manufacturing PMI climbed to 57.7 in February from 54.8 in January, while services PMI fell to 44.7 from 45.4. Eurozone’s current account surplus increased to EUR 51.9 billion in December from EUR 33.4 billion in the year-ago month.
The annual inflation rate in France rose to 0.6% in January, while German producer prices rose 0.9% year-on-year in January. Retail sales in the UK tumbled 8.2% in January.
Economics
The IHS Markit manufacturing PMI declined to 58.5 in February from 59.2 in January, while services PMI climbed to 58.9 in February from 58.3 in the prior month.
US existing home sales rose 0.6% to 6.69 million units in January.
The total number of active U.S. oil rigs slipped by 1 to 305 rigs this week, Baker Hughes Inc reported.
Toward the end of trading Friday, the Dow traded up 0.09% to 31,520.48 while the NASDAQ rose 0.02% to 13,868.58. However, the S&P fell 0.18% to 3,906.96.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 27,896,700 cases with around 493,110 deaths. India confirmed a total of at least 10,963,390 confirmed cases and 156,110 deaths, while Brazil reported over 10,030,620 COVID-19 cases with 243,450 deaths. In total, there were at least 110,394,360 cases of COVID-19 worldwide with over 2,443,540 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Industrials shares rose 1.5% on Friday. Meanwhile, top gainers in the sector included Energous Corporation WATT 72.04%, up 68%, and The ExOne Company XONE 15.04%, up 16%.
In trading on Friday, utilities shares fell by 1.3%.
Top Headline
Deere & Company DE 10.82% reported better-than-expected earnings for its fourth quarter.
Deere reported quarterly earnings of $3.87 per share, beating analysts’ estimates of $2.16 per share. The company’s quarterly sales came in at $9.11 billion, versus expectations of $7.21 billion.
Equities Trading UP
Vaccinex, Inc. VCNX 85.71% shares shot up 88% to $5.40 after the company announced the signing of multiproject deals with two prominent pharma companies that Vaccinex did not identify. The collaborations, Vaccinex said, will focus on using ActivMAb, its antibody discovery and novel viral display platform, for antibody discovery against complex antigens such as GPCRs and ion channels.
Shares of Evolus, Inc. EOLS 68.57% got a boost, shooting 70% to $12.17. Evolus, AbbVie, and Medytox announced settlement agreements to fully resolve all outstanding litigation, including the United States International Trade Commission (ITC) case regarding the sale of Jeuveau. It is a prescription medicine injected into muscles and used in adults temporarily to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines).
Casa Systems Inc CASA 36.8% shares were also up, gaining 37% to $11.67 after the company reported better-than-expected Q4 results and issued strong FY21 sales guidance.
Check out these big movers of the day
Equities Trading DOWN
PDF Solutions, Inc. PDFS 14.15% shares tumbled 14% to $18.28 after reporting a loss for the fourth quarter.
Shares of Rackspace Technology, Inc. RXT 16.61% were down 15% to $21.14 after the company issued FY21 earnings guidance below estimates.
Conduent Incorporated CNDT 12.89% was down, falling 14% to $4.99 after the company reported Q4 earnings results.
Commodities
In commodity news, oil traded down 1.6% to $59.53, while gold traded up 0.3% to $1,779.70.
Silver traded up 1% Friday to $27.335 while copper rose 4.2% to $4.0660.
Euro zone
European shares closed higher today. The eurozone’s STOXX 600 rose 0.53%, the Spanish Ibex Index rose 1.16% and the German DAX 30 gained 0.77%. Meanwhile, the French CAC 40 rose 0.79%, London’s FTSE 100 rose 0.1% and Italy’s FTSE MIB rose 0.94%.
The Eurozone manufacturing PMI climbed to 57.7 in February from 54.8 in January, while services PMI fell to 44.7 from 45.4. Eurozone’s current account surplus increased to EUR 51.9 billion in December from EUR 33.4 billion in the year-ago month.
The annual inflation rate in France rose to 0.6% in January, while German producer prices rose 0.9% year-on-year in January. Retail sales in the UK tumbled 8.2% in January.
Economics
The IHS Markit manufacturing PMI declined to 58.5 in February from 59.2 in January, while services PMI climbed to 58.9 in February from 58.3 in the prior month.
US existing home sales rose 0.6% to 6.69 million units in January.
The total number of active U.S. oil rigs slipped by 1 to 305 rigs this week, Baker Hughes Inc reported.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.